Major Progress in Next Generation Medicines Initiative

4 months ago

Nottingham, UK – Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has reached a key milestone in its work with CrystecPharma and the Advanced Manufacturing Supply Chain Initiative (AMSCI) to create a new platform to accelerate drug development. The contract development and manufacturing organisation (CDMO) now has CrystecPharma’s supercritical fluid technology platform